Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101659668A discloses novel routes for Irinotecan and Topotecan intermediates, offering significant cost reduction in API manufacturing through improved oxidation and alkylation strategies.
Patent CN102010376B details an aqueous phase synthesis for quinoxalines using biodegradable ionic liquids, offering high yields and eco-friendly processing for pharmaceutical intermediates.
Patent CN112574225A details a room-temperature gold-catalyzed synthesis of tetrahydrofuran dihydroquinolines, offering high yields and simplified processing for pharmaceutical supply chains.
Patent CN103012319B reveals high-yield DEPBT method for repaglinide intermediates, ensuring supply chain stability and cost reduction.
Novel 3-step route using 2-amino-5-methylbenzoic acid ensures high purity >99% and cost reduction in obesity drug manufacturing.
Novel high-yield synthesis of LND1067 linker for ADCs. Optimized route avoids low-yield intermediates, ensuring cost reduction and supply reliability for pharmaceutical manufacturing.
Patent CN103450073A details a novel rigid chiral catalyst synthesis offering superior stereoselectivity and cost-effective manufacturing for complex pharmaceutical intermediates.
Patent CN110067006A reveals metal-free electrochemical route for antitumor indoles, offering green manufacturing and supply chain advantages for pharma intermediates.
Patent CN103649055B reveals high-yield pyrazole synthesis for DPP-IV inhibitors, offering cost reduction and scalable supply chain solutions for pharma manufacturers.
Patent CN112851674B reveals a novel rhodium-catalyzed double dehydrogenative coupling method for polysubstituted pyrroles, offering high efficiency and functional group diversity for industrial applications.
Patent CN1865234A reveals mild Wittig route for cis-capsaicin. Offers cost reduction and scalable supply for flavor and pharma industries.
Patent CN103333049A reveals a recyclable phosphotungstic acid ionic liquid catalyst for styrene oxide alcoholysis, offering high purity and reduced waste for pharmaceutical intermediate manufacturing.
Novel Cu-Ni catalytic method for high-purity pharmaceutical intermediates. Reduces cost and improves supply chain reliability for global buyers seeking stable production.
Discover the novel one-step preparation and resolution of 2-acylamino-3-biphenylpropionic acid. A cost-effective, high-purity route for API manufacturing.
Novel Ni-catalyzed desulfitative coupling of sulfonyl chlorides offers high yield and broad scope. A cost-effective route for API intermediates and fine chemicals.
Novel Pd-catalyzed C-H activation method ensures 99% ee. Reliable supplier for scalable chiral amine manufacturing with cost efficiency.
Novel catalytic hydrogenation route for Lenalidomide. High purity, reduced solvent use, scalable manufacturing for API intermediates.
Patent CN115403494B enables air-oxidized, metal-free synthesis of beta-hydroxy sulfones. Delivers high purity, cost efficiency, and scalable supply for pharmaceutical intermediates.
Novel Rh-catalyzed Zolpidem synthesis offers high purity and reduced toxic waste. Ideal for scalable pharmaceutical intermediate manufacturing and supply chain optimization.
Patent CN116354930A reveals a novel Pd/Cu catalyzed route for synthesizing chiral tetrahydroquinolines from amino acids, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.